Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PilZ domain-containing proteins are a large family of bacterial signaling proteins that serve as the primary cytoplasmic receptors for the second messenger cyclic diguanylate (c-di-GMP)[1][3]. The canonical PilZ domain is characterized by a conserved structure of six β-strands followed by a C-terminal α-helix, forming a binding site for c-di-GMP through specific sequence motifs (RxxxR and D/NxSxxG)[2][3]. Binding of c-di-GMP induces conformational changes that enable the PilZ domain to regulate the activity of its target proteins, acting either as a cis- or trans-regulatory domain[1]. These proteins are widely distributed in bacteria and are involved in diverse processes such as motility (e.g., acting as a “flagellar brake”), biofilm formation, cellulose synthesis, and type IV pilus biogenesis[1][3][6]. Elevated intracellular c-di-GMP, sensed by PilZ domains, generally promotes a switch from a motile, planktonic lifestyle to a sessile, biofilm-forming state[3]. There are also atypical and divergent PilZ-related domains with varied structures and functions, some of which have lost c-di-GMP binding capacity but retain roles in pilus regulation or other cellular processes[2]. While the PilZ domain itself is not currently a direct therapeutic target, its central role in bacterial virulence and biofilm formation makes it a potential indirect target for anti-infective strategies[1][3][6]. However, there are no known drugs that directly interact with the PilZ domain, and its primary significance is in bacterial physiology and pathogenesis[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PilZ domain-containing protein (PilZ).